[{"address1": "4300 El Camino Real", "address2": "Suite 210", "city": "Los Altos", "state": "CA", "zip": "94022", "country": "United States", "phone": "650 351 4495", "website": "https://unicycive.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California.", "fullTimeEmployees": 22, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shalabh K. Gupta M.D., MPA", "age": 51, "title": "Founder, Chairman, CEO & President", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1100000, "exercisedValue": 0, "unexercisedValue": 141224}, {"maxAge": 1, "name": "Dr. Pramod  Gupta Ph.D.", "age": 64, "title": "Executive Vice President of Pharmaceutical & Business Operations", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 675000, "exercisedValue": 0, "unexercisedValue": 40969}, {"maxAge": 1, "name": "Mr. Douglas  Jermasek M.B.A.", "age": 62, "title": "Executive Vice President of Corporate Strategy", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 412500, "exercisedValue": 0, "unexercisedValue": 42029}, {"maxAge": 1, "name": "Mr. John W. Townsend CPA", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 197864, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.64, "open": 0.637, "dayLow": 0.6323, "dayHigh": 0.6499, "regularMarketPreviousClose": 0.64, "regularMarketOpen": 0.637, "regularMarketDayLow": 0.6323, "regularMarketDayHigh": 0.6499, "payoutRatio": 0.0, "beta": 2.147, "forwardPE": -3.1999998, "volume": 222094, "regularMarketVolume": 212068, "averageVolume": 964973, "averageVolume10days": 557530, "averageDailyVolume10Day": 557530, "bid": 0.6158, "ask": 0.663, "bidSize": 6, "askSize": 4, "marketCap": 76611200, "fiftyTwoWeekLow": 0.202, "fiftyTwoWeekHigh": 1.289, "fiftyDayAverage": 0.58292, "twoHundredDayAverage": 0.525385, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 51150216, "profitMargins": 0.0, "floatShares": 70600827, "sharesOutstanding": 119705000, "sharesShort": 1713889, "sharesShortPriorMonth": 1399359, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0143, "heldPercentInsiders": 0.05308, "heldPercentInstitutions": 0.52366, "shortRatio": 2.07, "shortPercentOfFloat": 0.0152, "impliedSharesOutstanding": 119705000, "bookValue": 0.065, "priceToBook": 9.846154, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -37824000, "trailingEps": -0.56, "forwardEps": -0.2, "enterpriseToEbitda": -1.594, "52WeekChange": -0.47540987, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 0.64, "targetHighPrice": 9.0, "targetLowPrice": 3.0, "targetMeanPrice": 6.21429, "targetMedianPrice": 7.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 26142000, "totalCashPerShare": 0.218, "ebitda": -32095000, "totalDebt": 681000, "quickRatio": 1.084, "currentRatio": 1.283, "debtToEquity": 9.164, "returnOnAssets": -0.87543, "returnOnEquity": -20.28106, "freeCashflow": -12170500, "operatingCashflow": -28575000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "UNCY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_605176729", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626096600000, "postMarketChangePercent": -1.09375, "postMarketPrice": 0.633, "postMarketChange": -0.00699997, "regularMarketChange": 0.0, "regularMarketDayRange": "0.6323 - 0.6499", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 964973, "fiftyTwoWeekLowChange": 0.43799996, "fiftyTwoWeekLowChangePercent": 2.1683166, "fiftyTwoWeekRange": "0.202 - 1.289", "fiftyTwoWeekHighChange": -0.64900005, "fiftyTwoWeekHighChangePercent": -0.5034911, "fiftyTwoWeekChangePercent": -47.540985, "earningsTimestamp": 1743418800, "earningsTimestampStart": 1743418800, "earningsTimestampEnd": 1743418800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.2, "epsCurrentYear": -0.204, "priceEpsCurrentYear": -3.137255, "fiftyDayAverageChange": 0.05707997, "fiftyDayAverageChangePercent": 0.09792076, "twoHundredDayAverageChange": 0.11461496, "twoHundredDayAverageChangePercent": 0.21815422, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-13", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Unicycive Therapeutics, Inc.", "longName": "Unicycive Therapeutics, Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.64, "corporateActions": [], "postMarketTime": 1745624026, "regularMarketTime": 1745611201, "displayName": "Unicycive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]